Scale-up vs scale-out: evaluating manufacturing scalability of CAR T cell therapy using process simulation tools
Cell & Gene Therapy Insights 2020; 6(8), 1047–1056
10.18609/cgti.2020.116
Published: 3 September 2020
Expert Insight
Graphical abstract
